Medical technology company Intuitive Surgical (NASDAQ: ISRG) will be reporting earnings this Thursday after the bell. Here’s what you need to know.

Intuitive Surgical beat analysts’ revenue expectations by 3% last quarter, reporting revenues of $2.51 billion, up 22.9% year on year. It was a stunning quarter for the company, with a beat of analysts’ EPS estimates and a solid beat of analysts’ revenue estimates.

Is Intuitive Surgical a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.

This quarter, analysts are expecting Intuitive Surgical’s revenue to grow 13.6% year on year to $2.74 billion, slowing from the 25.2% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $2.27 per share.

Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Intuitive Surgical has a history of exceeding Wall Street’s expectations, beating revenue estimates every single time over the past two years by 2.7% on average.

Looking at Intuitive Surgical’s peers in the healthcare equipment and supplies segment, only Neogen has reported results so far. It beat analysts’ revenue estimates by 7.2%, posting year-on-year sales declines of 2.8%. The stock traded up 30.4% on the results.

Investors in the healthcare equipment and supplies segment have had steady hands going into earnings, with share prices up 1.6% on average over the last month. Intuitive Surgical is down 8.8% during the same time.

Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we’ve identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link.